ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2025
Predictive potential of hepatocyte growth factor and bone morphogenetic proteins in lymphatic metastasis of breast cancer.
Article in Translational breast cancer research : a journal focusing on translational research in breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lymph node metastasis is an important predictive factor for the prognosis of breast cancer. Bone morphogenetic protein (BMP) and hepatocyte growth factor (HGF), and its receptor MET, are involved in metastasis. However, their predictive potential in the prediction of lymph node metastasis from breast cancer has not been evaluated to date. The aim of this study is to evaluate the implication of HGF and BMPs in breast cancer lymphatic metastasis. Methods: The association between the ligands and receptors of BMP, the regulators of HGF, and the modulators of MET were detected in Cardiff clinical breast cancer cohort and The Cancer Genome Atlas (TCGA) breast cancer ribonucleic acid (RNA) sequencing database. Predictive model of HGF and BMPs for nodal metastasis was evaluated by binary logistic regression and receiver operating characteristic (ROC) curve. Results: BMP-2 expression was upregulated but BMP-7 and matriptase-2 expression were downregulated in patients with nodal metastases. MET, matriptase-1, BMP-15, HAI-1, and matriptase-2 were correlated with the lymphangiogenesis markers. Lymphatic metastasis was positively with MET, matriptase-1 and BMP-15 but was negatively with matriptase-2, BMP-3, and HAI-1. ROC curve analysis showed the six factors with nodal status had a significant area under the curve values (0.657, P=0.001). The integrated signature could effectively predict lymph nodes involvement (P=0.006, hazard ratio =2.929). Conclusions: The aberrant expression of HGF/MET and BMPs is related to lymphatic metastasis in breast cancer. Integrated expression level of MET/BMP-15/matriptase-1 and the inversed HAI-1/BMP-3/matriptase-2 establishes a predictive model for lymph node involvement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.